David Morris, MDOriginally from Cleveland in East Tennessee, Dr. Morris attended The Baylor School in Chattanooga, TN. He graduated Summa Cum Laude from Vanderbilt University and then earned his doctorate from Vanderbilt University School of Medicine. Dr. Morris completed his residency training at The University of Michigan in Ann Arbor, MI with a special research interest in genetics that predict the aggressiveness of prostate and bladder cancers. Since completion of training, he has been with Urology Associates in Nashville, Tennessee. He serves the group President and the Co-director for the Advanced Therapeutics Center. The ATC center also works closely with the Clinical Research Department as a center for multiple phase 2 and 3 trials primarily focused on GU oncology. Dr. Morris has served LUGPA as a member of its education committee, program committee and as co-chair of LUGPA Forward. He was elected to the LUGPA Board of Directors in 2023. |
Announcements
A Survey of Patient Understanding of Muscle Invasive Bladder Cancer Treatment
Now Enrolling!
Learn How You Can Refer Patients
Join the Women’s Urologic Health Alliance
Subscribe to be a part of the discussion, receive WUHA news and announcements.
Learn how to have your facility become a SRC/NAFC Center of Excellence In Continence Care for Women. LUGPA groups will receive a discount on certification fees.
LUGPA members can login to access past content On Demand.